chr1-151763029-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_031420.4(MRPL9):āc.271A>Gā(p.Lys91Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000316 in 1,614,222 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_031420.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MRPL9 | NM_031420.4 | c.271A>G | p.Lys91Glu | missense_variant | 2/7 | ENST00000368830.8 | NP_113608.1 | |
OAZ3 | NM_001134939.1 | c.-107T>C | 5_prime_UTR_variant | 1/5 | NP_001128411.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MRPL9 | ENST00000368830.8 | c.271A>G | p.Lys91Glu | missense_variant | 2/7 | 1 | NM_031420.4 | ENSP00000357823 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000112 AC: 17AN: 152234Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000835 AC: 21AN: 251418Hom.: 0 AF XY: 0.0000662 AC XY: 9AN XY: 135912
GnomAD4 exome AF: 0.0000233 AC: 34AN: 1461870Hom.: 0 Cov.: 31 AF XY: 0.0000151 AC XY: 11AN XY: 727236
GnomAD4 genome AF: 0.000112 AC: 17AN: 152352Hom.: 0 Cov.: 33 AF XY: 0.0000940 AC XY: 7AN XY: 74496
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 01, 2023 | The c.271A>G (p.K91E) alteration is located in exon 2 (coding exon 2) of the MRPL9 gene. This alteration results from a A to G substitution at nucleotide position 271, causing the lysine (K) at amino acid position 91 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at